CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 24 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $169,163 | -8.9% | 110,564 | 0.0% | 0.00% | – |
| Q1 2024 | $185,748 | -6.6% | 110,564 | -0.4% | 0.00% | – |
| Q4 2023 | $198,860 | -5.2% | 110,990 | 0.0% | 0.00% | – |
| Q3 2023 | $209,771 | +25.5% | 110,990 | -2.4% | 0.00% | – |
| Q2 2023 | $167,126 | -35.0% | 113,691 | -13.8% | 0.00% | – |
| Q1 2023 | $257,279 | -18.7% | 131,938 | -6.2% | 0.00% | – |
| Q4 2022 | $316,396 | -6.4% | 140,620 | +0.2% | 0.00% | – |
| Q3 2022 | $338,000 | +15.8% | 140,350 | +0.1% | 0.00% | – |
| Q2 2022 | $292,000 | -25.5% | 140,248 | +1.0% | 0.00% | – |
| Q1 2022 | $392,000 | -39.0% | 138,902 | +0.8% | 0.00% | – |
| Q4 2021 | $643,000 | -27.9% | 137,733 | -58.6% | 0.00% | – |
| Q3 2021 | $892,000 | -20.9% | 333,051 | -15.9% | 0.00% | – |
| Q2 2021 | $1,127,000 | +2.3% | 396,024 | +9.0% | 0.00% | – |
| Q1 2021 | $1,102,000 | +3.0% | 363,445 | +0.3% | 0.00% | – |
| Q4 2020 | $1,070,000 | -8.6% | 362,411 | -0.7% | 0.00% | – |
| Q3 2020 | $1,171,000 | -1.6% | 364,974 | +2.1% | 0.00% | – |
| Q2 2020 | $1,190,000 | +0.1% | 357,420 | +9.1% | 0.00% | – |
| Q1 2020 | $1,189,000 | -30.4% | 327,615 | -1.2% | 0.00% | – |
| Q4 2019 | $1,708,000 | -13.3% | 331,559 | -0.2% | 0.00% | – |
| Q3 2019 | $1,969,000 | -7.0% | 332,156 | -0.1% | 0.00% | – |
| Q2 2019 | $2,118,000 | +28.4% | 332,543 | +17.2% | 0.00% | – |
| Q1 2019 | $1,650,000 | -10.9% | 283,790 | -7.5% | 0.00% | – |
| Q4 2018 | $1,851,000 | +2.5% | 306,901 | -3.0% | 0.00% | – |
| Q3 2018 | $1,805,000 | -10.8% | 316,232 | -4.3% | 0.00% | – |
| Q2 2018 | $2,024,000 | -8.9% | 330,318 | -0.7% | 0.00% | – |
| Q1 2018 | $2,221,000 | -20.0% | 332,482 | -11.9% | 0.00% | – |
| Q4 2017 | $2,777,000 | -0.1% | 377,217 | -4.2% | 0.00% | – |
| Q3 2017 | $2,781,000 | -0.8% | 393,890 | -1.6% | 0.00% | – |
| Q2 2017 | $2,803,000 | -3.5% | 400,445 | -4.3% | 0.00% | – |
| Q1 2017 | $2,904,000 | – | 418,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |
| JPMORGAN CHASE & CO | 10 | $19 | 0.00% |
| TWO SIGMA ADVISERS, LP | 23,600 | $44,604 | 0.00% |
| Tower Research Capital LLC (TRC) | 5,032 | $9,510 | 0.00% |